Phoenix strengthen its team as they approach First in Man studies.

We are delighted to announce that Dr. Robert Miller from Artemida Pharma will take on a role as Chief Medical Officer at Phoenix. We have been working closely with Robert over the past 18 months and he has been instrumental in carving out our current clinical plan and strategy, which has recently been validated at scientific advisory meetings with UK’s MHRA and Norwegian NOMA. In addition, Dr. Sarah Arbe-Barnes (Artemida) will take on a role as Project Manager with particular responsibility for the execution of our clinical program. We look very much forward to continuing our collaborations with Artemida Pharma to bring ACT® into the clinic.


About Artemida Pharma: 

Artemida Pharma is an established specialist drug development consultancy whose highly experienced scientists represent multiple disciplines and therapeutic areas. Artemida Pharma offers optimised strategic drug development and project management to start-up, biopharma and mid-sized pharma companies.